Spinal Opioid Therapy Changes the Chemical Environment of Cancer Pain Patients' Spinal Fluid
Cancer pain patients had altered CSF neuropeptide profiles, and starting spinal opioid therapy further modified these levels while reducing pain.
Quick Facts
What This Study Found
Cancer pain patients had altered CSF neuropeptide profiles. Spinal opioid therapy changed pain scores and further modified CSF peptide levels.
Key Numbers
How They Did This
CSF collected from 10 cancer pain patients before and after spinal opioid therapy initiation, and from 10 controls. Seven neuropeptides measured by radioimmunoassay. Pain rated by VAS.
Why This Research Matters
Effective pain treatment changes the spinal cord's chemical environment, not just pain perception. This could help optimize pain treatment by monitoring neuropeptide responses.
The Bigger Picture
Pain treatment doesn't just block signals — it reshapes the spinal cord's chemical environment. Monitoring CSF neuropeptides could help personalize pain management, especially for cancer patients who need long-term relief.
What This Study Doesn't Tell Us
Small study (10 patients). No placebo control for the opioid therapy. CSF sampling is invasive. Multiple peptides measured increases chance of false positives.
Questions This Raises
- ?Could CSF neuropeptide profiles guide opioid dose adjustments?
- ?Do certain neuropeptide patterns predict better response to spinal opioid therapy?
Trust & Context
- Key Stat:
- 7 peptides, all changed Cancer pain altered CSF profiles of opioid and sensory neuropeptides, and spinal opioid therapy further modified them
- Evidence Grade:
- Moderate — clinical study with paired before/after measurements in cancer patients. Small sample and no placebo control, but clinically meaningful.
- Study Age:
- Published in 1993 (33 years ago). CSF neuropeptide monitoring in pain management has advanced but remains primarily research-based.
- Original Title:
- CSF neuropeptides in cancer pain: effects of spinal opioid therapy.
- Published In:
- Acta anaesthesiologica Scandinavica, 37(5), 502-8 (1993)
- Authors:
- Samuelsson, H, Ekman, R(5), Hedner, T
- Database ID:
- RPEP-00276
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
What changes in spinal fluid during cancer pain?
Cancer pain alters the levels of multiple neuropeptides in the spinal fluid — both the body's natural painkillers (opioid peptides) and pain-signaling molecules (substance P, CGRP). This reflects the spinal cord's response to chronic pain.
Why does treatment change these levels further?
Spinal opioid therapy doesn't just block pain signals — it triggers the spinal cord to adjust its own chemical messengers. Understanding these changes could help doctors fine-tune treatment for better pain control.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00276APA
Samuelsson, H; Ekman, R; Hedner, T. (1993). CSF neuropeptides in cancer pain: effects of spinal opioid therapy.. Acta anaesthesiologica Scandinavica, 37(5), 502-8.
MLA
Samuelsson, H, et al. "CSF neuropeptides in cancer pain: effects of spinal opioid therapy.." Acta anaesthesiologica Scandinavica, 1993.
RethinkPeptides
RethinkPeptides Research Database. "CSF neuropeptides in cancer pain: effects of spinal opioid t..." RPEP-00276. Retrieved from https://rethinkpeptides.com/research/samuelsson-1993-csf-neuropeptides-in-cancer
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.